The FDA approved more rare disease therapies than non-rare disease drugs between 2020 and 2025

The FDA gave the greenlight to between 20 and 31 rare disease therapies during a five-year period. Click below to view the rate of rare and non-rare disease approvals for the EMA:
EMA approvals between 2020 and 2025